IL27 and atherosclerosis: Based on these observations, we suggest that, in the context of the IL27-induced vascular inflammation, calprotectin might be a novel attractive candidate as a regulator of monocyte recruitment to early atherosclerotic lesions, hence preventing the progression of inflammation and atherosclerosis.